After Inking Distribution Deal with Thermo, Osmetech Plans New Tests, Financing Rounds | GenomeWeb

Osmetech said last week that Fisher HealthCare, a division of Thermo Fisher Scientfic, will now distribute its eSensor XT-8 instrument array platform and accompanying molecular diagnostic tests and consumables in the US.

The five-year distribution agreement will enable Osmetech to take advantage of Fisher Healthcare's "considerable sales and marketing strength" and "established relationship with key customer accounts," according to Osmetech.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.